Concepedia

Author

P. Pasanen

Kuopio University Hospital

Also Known As

P A Pasanen, P PASANEN, P Pasanen, P. A. Pasanen, P. Pasanen, PA Pasanen, Pentti Pasanen, Pertti Pasanen

38

Publications

809

Citations

15

H-Index

56

Concepts

All Affiliations

Kuopio University HospitalUniversity of Eastern Finland
PP

About

P. Pasanen is an author at Kuopio University Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

279

2

Health Sciences

4

4

70

3

Natural Sciences

3

3

224

4

Engineering

1

1

157

5

Anesthesia

1

1

14

P. Pasanen

×

20

Publications

742

Citations

15

H-Index

YearCitations

Survival of reared and wild Atlantic salmon smolts: size matters more in bad years

Irma Saloniemi, Erkki Jokikokko, Irma Kallio‐Nyberg,

ICES Journal of Marine Science

2004

157

A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis.

P. Pasanen, Kaarina Partanen, P Pikkarainen,

PubMed

1993

95

Ultrasonography, CT, and ERCP in the Diagnosis of Choledochal Stones

P. Pasanen, Kaarina Partanen, P Pikkarainen,

Acta Radiologica

1992

94

Acute abdominal pain in adults.

Pekka Miettinen, P. Pasanen, J Lahtinen,

PubMed

1996

60

Responses of spruce seedlings (Picea abies) to exhaust gas under laboratory conditions— I plant–insect interactions

Eeva-Liisa Viskari, Jouni Surakka, P. Pasanen,

Environmental Pollution

2000

44

The outcome of elderly patients after operation for acute abdomen.

Pekka Miettinen, P. Pasanen, Anne Salonen,

PubMed

1996

28

Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma

P. Pasanen, Matti Eskelinen, Kaarina Partanen,

British Journal of Cancer

1992

27

Diagnostic Accuracy of Ultrasound, Computed Tomography, and Endoscopic Retrograde Cholangiopancreatography in the Detection of Obstructive Jaundice

P. Pasanen, Kaarina Partanen, P Pikkarainen,

Scandinavian Journal of Gastroenterology

1991

26

Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.

Matti Eskelinen, P. Pasanen, A. Kulju,

PubMed

1994

25

Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242

P. Pasanen, Matti Eskelinen, A. Kulju,

Scandinavian Journal of Clinical and Laboratory Investigation

1995

24

Page 1